Table 4

Cardiac specialist and CR program perceptions of CR wait times in calendar days
Indication CCS wait time benchmarks Specialist responses, N = 71 mean ± SD (median) CR program responses, N = 92 mean ± SD (median)
Preferable Acceptable % of patients meeting preferable benchmark % of patients meeting acceptable benchmark Perception of appropriate # days wait % of patients meeting preferable benchmark % of patients meeting acceptable benchmark Perception of appropriate # days wait Perception of feasible # days wait
CABG 21-30 30-60 25.4 ± 25.0 (20) 49.5 ± 31.5 (50) 40.0 ± 20.7 (30) 34.1 ± 36.5 (20) 63.3 ± 32.8 (73)** 30.0 ± 17.2 (30)* 43.4 ± 30.9 (42)†††
Valvular disease 21-30 30-60 25.6 ± 25.6 (20) 46.0 ± 31.6 (50) 40.2 ± 20.2 (30) 34.2 ± 36.5 (20) 64.2 ± 33.6 (75)** 29.2 ± 15.9 (30)** 42.0 ± 31.6 (41)†††
Percutaneous coronary intervention 2-7 7-60 17.7 ± 24.7 (10) 54.4 ±33.4 (60) 20.5 ± 12.6 (14) 21.8 ± 31.3 (7) 68.1 ± 32.6 (75)* 14.7 ± 12.5 (10)* 31.7 ± 35.7 (20)†††
Myocardial infarction 7-30 30-60 34.1 ± 27.7 (30) 54.0 ± 31.8 (50) 28.2 ± 18.0 (30) 37.5 ± 35.3 (30) 58.5 ± 33.1 (60) 20.6 ± 16.1 (17)* 36.0 ± 35.3 (21)†††
Heart failure 7-30 30-60 25.3 ±24.4 (20) 42.0 ± 33.2 (30) 29.0 ± 17.9 (30) 34.8 ± 35.8 (21) 58.9 ± 36.0 (60)* 17.5 ± 13.3 (14)*** 30.5 ± 28.5 (22)††
Stable angina 7-30 30-60 30.1 ± 27.9 (20) 43.5 ± 32.9 (40) 34.2 ± 20.7 (30) 39.9 ± 35.2 (30) 58.1 ± 34.9 (60)* 18.9 ± 17.9 (14)*** 33.6 ± 36.9 (21)††
Heart transplantation 4-10 10-60 36.1 ± 40.6 (25) 41.1 ± 40.4 (25) 43.2 ± 125.5 (21) 18.5 ± 28.6 (0) 52.9 ± 39.9 (56) 26.2 ± 19.0 (21) 34.3 ± 22.0 (30)††
Arrhythmias 1-30 30-60 41.9 ± 121.7 (20) 53.8 ± 118.5 (21) 47.4 ± 104.3 (30) 34.8 ± 35.0 (22) 57.5 ± 35.0 (60)** 18.0 ± 15.5 (14)*** 36.0 ± 37.6 (21)†††

*Note: CABG = coronary artery bypass grafting; CCS = Canadian Cardiovascular Society; CR = cardiac rehabilitation.

*p < 0.05; **p < 0.01; ***p < 0.001, independent samples t-tests comparing specialists with CR program perceptions of the percentage of patients meeting preferable and acceptable benchmarks, and of the appropriate number of days’ wait.

†p < 0.05; ††p < 0.01; †††p < 0.001 for related-samples Wilcoxon signed rank tests comparing CR program perceptions of appropriate versus feasible number of days’ wait by type of cardiac indication for CR.

Grace et al.

Grace et al. BMC Health Services Research 2012 12:259   doi:10.1186/1472-6963-12-259

Open Data